Trial NCT03190967

View at ClinicalTrials.gov 
Org. Study IDs: 170115
Secondary IDs: 17-C-0115

Last trial update was posted on 2023-10-11

MeSH Interventions

Temozolomide Trastuzumab

MeSH Conditions

Brain Neoplasms Breast Neoplasms Neoplasm Metastasis

Other Conditions

Brain Cancer Brain Metastasis Breast Cancer

Stopping Reasons

The phase II portion was never started as we could no longer get the drug from the manufacturer.

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID